The California Institute for Regenerative Medicine (CIRM) is pleased to announce the opening of our next round of Quest Awards (DISC2) for discovery stage research.

The purpose of the Quest Awards is to promote discovery of promising new stem cell-based and/or gene therapy technologies that could be translated to enable broad use and ultimately, improve patient care. The expected outcome, at the end of the award, is a candidate therapeutic or technology that can immediately progress to translational stage activities.

Applications are due May 2nd, 2023 at 2:00 PM PDT. Please visit this page on CIRM’s website for application instructions.

CIRM encourages the submission of proposals to advance the treatment and/or understanding of central nervous system (CNS) disorders.  

Important Update: Please note that the DISC2 Program Announcement (PA) has been updated since the last round of applications. In addition, CIRM has implemented new guidelines and requirements for data sharing in our Discovery programs.

Please read the new PA and review the Information for Applicants page on our website before submitting your application. Interested applicants may contact discovery@cirm.ca.gov with any additional questions.

Sign Up for an Informational Webinar

Have questions about this funding opportunity? Join the CIRM Scientific Programs team for an informational webinar.

This webinar provides an opportunity for prospective applicants to learn more about CIRM’s DISC2 Quest Awards and how to assemble a competitive application. Click here to register for the webinar.

The CIRM team will elaborate on DISC2 eligibility requirements, the application and review process, and how this program fits into CIRM’s R&D Pillar initiatives as well as our Strategic Plan and Mission.

The webinar includes a half-hour presentation by CIRM staff followed by a half-hour for Q&A.

We look forward to your applications!